Correlation Between Cardiff Oncology and Instil Bio
Can any of the company-specific risk be diversified away by investing in both Cardiff Oncology and Instil Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiff Oncology and Instil Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardiff Oncology and Instil Bio, you can compare the effects of market volatilities on Cardiff Oncology and Instil Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiff Oncology with a short position of Instil Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiff Oncology and Instil Bio.
Diversification Opportunities for Cardiff Oncology and Instil Bio
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cardiff and Instil is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Cardiff Oncology and Instil Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instil Bio and Cardiff Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiff Oncology are associated (or correlated) with Instil Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instil Bio has no effect on the direction of Cardiff Oncology i.e., Cardiff Oncology and Instil Bio go up and down completely randomly.
Pair Corralation between Cardiff Oncology and Instil Bio
Given the investment horizon of 90 days Cardiff Oncology is expected to generate 0.81 times more return on investment than Instil Bio. However, Cardiff Oncology is 1.23 times less risky than Instil Bio. It trades about 0.0 of its potential returns per unit of risk. Instil Bio is currently generating about 0.0 per unit of risk. If you would invest 346.00 in Cardiff Oncology on August 6, 2025 and sell it today you would lose (124.00) from holding Cardiff Oncology or give up 35.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardiff Oncology vs. Instil Bio
Performance |
| Timeline |
| Cardiff Oncology |
| Instil Bio |
Cardiff Oncology and Instil Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardiff Oncology and Instil Bio
The main advantage of trading using opposite Cardiff Oncology and Instil Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiff Oncology position performs unexpectedly, Instil Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instil Bio will offset losses from the drop in Instil Bio's long position.| Cardiff Oncology vs. Alto Neuroscience, | Cardiff Oncology vs. PepGen | Cardiff Oncology vs. Actuate Therapeutics, Common | Cardiff Oncology vs. Applied Therapeutics |
| Instil Bio vs. Equillium | Instil Bio vs. Panacea Biotec Limited | Instil Bio vs. Race Oncology | Instil Bio vs. Cambium Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |